Role of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer Cells
AbstractCancer is one of the most common causes of death among adults. Chemotherapy is crucial in determining patient survival and quality of life. However, the development of multidrug resistance (MDR) continues to pose a significant challenge in the management of cancer. In this study, we analyzed the role of human ribosomal protein uL3 (formerly rpL3) in multidrug resistance. Our studies revealed that uL3 is a key determinant of multidrug resistance in p53-mutated lung cancer cells by controlling the cell redox status. We established and characterized a multidrug resistant Calu-6 cell line. We found that uL3 down-regulation correlates positively with multidrug resistance. Restoration of the uL3 protein level re-sensitized the resistant cells to the drug by regulating the reactive oxygen species (ROS) levels, glutathione content, glutamate release, and cystine uptake. Chromatin immunoprecipitation experiments and luciferase assays demonstrated that uL3 coordinated the expression of stress-response genes acting as transcriptional repressors of solute carrier family 7 member 11 (xCT) and glutathione S-transferase α1 (GST-α1), independently of Nuclear factor erythroid 2-related factor 2 (Nrf2). Altogether our results describe a new function of uL3 as a regulator of oxidative stress response genes and advance our understanding of the molecular mechanisms underlying multidrug resistance in cancers. View Full-Text
- Supplementary File 1:
PDF-Document (PDF, 1129 KB)
Share & Cite This Article
Russo, A.; Saide, A.; Smaldone, S.; Faraonio, R.; Russo, G. Role of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer Cells. Int. J. Mol. Sci. 2017, 18, 547.
Russo A, Saide A, Smaldone S, Faraonio R, Russo G. Role of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer Cells. International Journal of Molecular Sciences. 2017; 18(3):547.Chicago/Turabian Style
Russo, Annapina; Saide, Assunta; Smaldone, Silvia; Faraonio, Raffaella; Russo, Giulia. 2017. "Role of uL3 in Multidrug Resistance in p53-Mutated Lung Cancer Cells." Int. J. Mol. Sci. 18, no. 3: 547.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.